Isotretinoïne Sun

Isotretinoin, the active ingredient in Isotretinoïne Sun, is a retinoid presented as an oral dosage form for systemic use. It is prescribed for severe forms of acne that have not responded to other therapies, targeting both inflammatory and non‑inflammatory lesions. GNH USA supplies Isotretinoïne Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Isotretinoïne Sun is a retinoid indicated for severe acne conditions that require systemic therapy. - Severe nodular acne: reduces the number and size of nodules and promotes skin clearance. - Acne vulgaris refractory to other therapy: improves lesions when topical and other oral agents have failed. - Severe cystic acne: decreases inflammatory cysts and prevents scarring.

Isotretinoïne Sun may cause a range of adverse reactions.

Common Side Effects: - Dry skin and mucous membranes, including cheilitis. - Elevated liver enzymes and triglyceride levels. - Increased photosensitivity and ocular dryness.

Serious or Rare Side Effects: - Severe depression or mood changes. - Teratogenic effects leading to birth defects. - Pancreatitis or severe hypertriglyceridemia.

Isotretinoïne Sun requires careful monitoring due to its potency and risk profile. - Pregnancy: contraindicated; ensure effective contraception before, during, and after therapy. - Liver function: monitor hepatic enzymes regularly. - Lipid profile: check triglycerides and cholesterol during treatment. - Vitamin A intake: avoid concomitant vitamin A supplements to prevent toxicity. - Mood changes: observe for signs of depression or suicidal ideation. - Store at below 25°C: keep in the original container, protect from moisture and light.

Isotretinoïne Sun can interact with several medications, necessitating vigilance.

Major Interactions (Avoid): - Vitamin A supplements: additive risk of hypervitaminosis A. - Tetracycline antibiotics: increased risk of intracranial hypertension.

Moderate Interactions (Monitor Closely): - Oral corticosteroids: may potentiate pseudotumor cerebri. - Anticonvulsants (e.g., phenobarbital, phenytoin): may reduce isotretinoin plasma levels. - Anticoagulants (e.g., warfarin): potential alteration of coagulation parameters.